| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6052876 | Journal of Cranio-Maxillofacial Surgery | 2013 | 7 Pages |
Abstract
For the first time, these results show a correlation between the efficacies of EGFR inhibitors and various MAGE-A subgroups in the treatment of HNSCC. Determining the MAGE-A status could help to improve the success of anti-tumour drug therapy. In addition, evaluating MAGE-A levels might be an important tool in the development of patient-specific treatment protocols.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Stefan Hartmann, Ulrike Kriegebaum, Nora Küchler, Grit Lessner, Roman C. Brands, Christian Linz, Tim Schneider, Alexander C. Kübler, Urs D.A. Müller-Richter,